• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Clinical Trial Registry Accuracy and Maintenance in ALS/MND Research
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition, Swallowing and Saliva
      • Activities of Daily Living and Occupational Therapy
      • Muscles, Mobility and Exercise
      • Respiratory Care
      • Speech and Communication
      • Voice Preservation
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • R.A.C.E. to Diagnose ALS/MND
  • Programs & Events
    • Calendar of Events
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
  • Members
    • Member Registration
    • Forgot Password

International Alliance

  • Profile
  • Topics Started
  • Replies Created
  • Engagements
  • Favorites

Favorite Forum Topics

  • Oh, bother! No topics were found here.

Primary Sidebar

Advocacy

  • Advocacy Toolkit

Approved Drugs

  • Nuedexta
  • Radicava/Edaravone
  • Riluzole/Tiglutik
  • Rozebalamin / Methylcobalamin
  • Tofersen/Qalsody

Drugs in Development

  • AB Science – Masitinib
  • NurOwn
  • Clene Nanomedicine – CNM-Au8
  • ILB
  • Kadimastem – AstroRx
  • Neuronata-R / Lenzumestrocel
  • NeuroSense – PrimeC
  • NP001
  • Prilenia Therapeutics – Pridopidine
  • SOD1 Therapies & Trials
  • SPG302
  • Regulatory T Cell Enhancing Therapies
  • Ulefnersen

Care services

  • Genetic Counselling & Testing
  • Mental Health Support
  • Nursing and Symptom Management
  • Nutrition, Swallowing and Saliva
  • Activities of Daily Living and Occupational Therapy
  • Muscles, Mobility and Exercise
  • Respiratory Care
  • Speech and Communication
  • Support for Family & Caregivers
  • Technology

Support for members

  • Alliance Support Grant
  • About the meetings

Programs & Events

  • Calendar of Events/Programs
  • Alliance Webinars
  • Alliance Meeting
  • Allied Professionals Forum
  • ALS/MND Connect
  • Global Day Calendar
  • March of Faces
  • International Symposium

About

  • Who We Are
  • Board of Trustees
  • Councils, Forums & Committees
    • PALS and CALS Advisory Council
    • Scientific Advisory Council
    • Advocacy and Public Policy Forum
    • Research Directors Forum
    • Governance Committee
    • Finance Committee
  • Staff
  • History
  • Newsletter Archive
    • Meetings
  • Awards

Upcoming Events

Nov 10
8:00 am - 9:00 am EST

Member Forum: AI Impacts

Nov 10
6:00 pm - 7:00 pm EST

Member Forum: AI Impacts

Nov 19
12:00 pm - 1:00 pm CST

Les Turner ALS Foundation Webinar: The Caregiver’s Journey

Nov 20
7:45 am - 5:15 pm MST

Canadian Society of Palliative Medicine: Palliative Horizons – Clinical Approaches to ALS and Parkinson’s

Nov 24
9:00 am - 10:30 am EST

Annual General Meeting

View Calendar

  • Kris Van Reusel, Belgium

    Kris Van Reusel, Belgium

  • Xian-Zhang Niu, China

    Xian-Zhang Niu, China

  • Carlos Alberto Arango, Colombia

    Carlos Alberto Arango, Colombia

  • Claudia Cominetti, Italy

    Claudia Cominetti, Italy

  • Andrietta, Italy

    Andrietta, Italy
    Andrietta

  • Ian Roberts, Australia

    Ian Roberts, Australia

  • Ailsa Malcolm-Hutton, UK

    Ailsa Malcolm-Hutton, UK

  • Imelda Arenas, Colombia

    Imelda Arenas, Colombia

  • Erwin Coppejans, Belgium

    Erwin Coppejans, Belgium

  • Robbie Caliste, UK

    Robbie Caliste, UK

  • Liam Dwyer, England

    Liam Dwyer, England

  • Carlos Alberto Báez Murillo, Colombia

    Carlos Alberto Báez Murillo, Colombia

  • Seckin McGuirk, England

    Seckin McGuirk, England

  • Ching-Liang Chu, Taiwan

    Ching-Liang Chu, Taiwan

  • Eddy Lefrancois, Canada

    Eddy Lefrancois, Canada

  • Federica Mastrosimone, Italy

    Federica Mastrosimone, Italy

  • Brigitte Wernli, Switzerland

    Brigitte Wernli, Switzerland

  • Mike Cels, Canada

    Mike Cels, Canada

  • Anna Barrow, UK

    Anna Barrow, UK

  • Alberto Baez Murillo, Colombia

    Alberto Baez Murillo, Colombia

  • Chun Ju Xiao, China

    Chun Ju Xiao, China

  • Lineke Veenstra, Netherlands

    Lineke Veenstra, Netherlands

  • Murat Morali, Turkey

    Murat Morali, Turkey

  • Duncan Bayly, Australia

    Duncan Bayly, Australia

  • Rosie Riley, USA

    Rosie Riley, USA

  • Shay Rishoni, Israel

    Shay Rishoni, Israel

  • Laurie Petit-Jean, France

    Laurie Petit-Jean, France

  • Shay Rishoni, Netherlands

    Shay Rishoni, Netherlands

  • Malu Araujo Ribeiro, Brazil

    Malu Araujo Ribeiro, Brazil

  • Michel Perrozzo, France

    Michel Perrozzo, France

  • Jon Newsome, USA

    Jon Newsome, USA

  • Alfredo Santos, Colombia

    Alfredo Santos, Colombia

  • Feng Gin Sun, China

    Feng Gin Sun, China

  • Tso-Ta Huang, Taiwan

    Tso-Ta Huang, Taiwan

  • Denis Blais, Canada

    Denis Blais, Canada

  • Liz Ogg, Scotland

    Liz Ogg, Scotland

  • Jan Zuring, Netherlands

    Jan Zuring, Netherlands

  • Willi Klein, UK

    Willi Klein, UK

  • Fabio Carvalho, Brazil

    Fabio Carvalho, Brazil

  • Joy Blakeley, Australia

    Joy Blakeley, Australia

  • Mike Rannie, Canada

    Mike Rannie, Canada

  • Antonio Ventriglia, Belgium

    Antonio Ventriglia, Belgium

  • Mona H. Bahus and Camilla Knoff Glomstad, Norway

    Mona H. Bahus and Camilla Knoff Glomstad, Norway

  • Eric Von Schaumburg, USA

    Eric Von Schaumburg, USA

  • Margarita Pizarro, Argentina

    Margarita Pizarro, Argentina

  • Karl Hughes, Ireland

    Karl Hughes, Ireland

  • Mirca Bersani, Italy

    Mirca Bersani, Italy
    MircaBersani

  • Stephanie Christiansen Hall, Canada

    Stephanie Christiansen Hall, Canada

  • Bjarne Hytjanstorp, Norway

    Bjarne Hytjanstorp, Norway

  • Dr. Shelly Hoover, USA

    Dr. Shelly Hoover, USA

Learn more about the March of Faces

Coronavirus (COVID-19) Resources

Instructions

First-time users, please register by clicking the register button below this log in form. You will then be able to create a user name and password. Only Alliance members are eligible to register.

If you have already registered, please use the details provided to log in using this form.

Drugs No Longer in Development

  • AMX0035
  • Reldesemtiv
  • Arimoclomol
  • TUDCA

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login